NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits can be filed on behalf of Bioventus Inc. BVSESSTech, Inc. GWH GWH.WT))), International Business Machines Corporation IBMand Fate Therapeutics, Inc. FATE. Shareholders have until the deadlines below to petition the court to be lead plaintiff. For more information on each case, see the link provided.

Bioventus Inc. BVS

Class Period: As per the IPO dated February 11, 2021

Lead Plaintiff Deadline: March 13, 2023

Bioventus is a medical technology company focused on the development and commercialization of clinical treatments to engage and enhance the body’s natural healing process.

On January 20, 2021, Bioventus filed a registration statement on Form S-1 with the SEC in connection with the IPO, which, after several amendments, was declared effective by the SEC on February 10, 2021 (the “Registration Statement”).

On or about February 11, 2021, pursuant to the registration statement, Bioventus completed its initial public offering and issued 8 million of its Class A common shares to the public at an offering price of $13.00 per share.

On February 12, 2021, Bioventus filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which includes and forms a part of the registration statement (the “Prospectus” and together with the registration statement, the “Offering Documents”). .

The offering documents were prepared negligently and as a result contained untrue statements of material facts or failed to state other facts necessary for the statements made to be misleading and were not prepared in accordance with the rules and regulations applicable to their preparation . In addition, throughout the Class Period, the Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. In particular, the offer documents …